Log in
Enquire now
Vaximm

Vaximm

Vaximm is developing oral T-cell immunotherapies to treat cancer patients.

OverviewStructured DataIssuesContributors
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Vaximm

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo